Live Quote · NASDAQPSTXHealthcare· Biotechnology

Poseida Therapeutics, Inc.

$9.50 0.00%(+$0.00)
TickerSpark Score
48/100
Weak
33
Valuation
20
Profitability
10
Growth
76
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PSTX research report →

52-Week Range98% of range
Low
$1.87
Current
$9.50
High
$9.67
Company Overviewwww.poseida.com

About the company

Poseida Therapeutics, Inc. , a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet medical needs. Its pipeline prominently features several advanced cell therapies.

CEO
Mark J. Gergen
IPO
2020
Employees
350
HQ
San Diego, CA, US

Price Chart

+195.03% · this period
$9.60$5.80$2.00Jan 09Jul 11Jan 08
Valuation
Market Cap
$925.93M
P/E
-6.93
P/S
14.31
P/B
8.26
EV/EBITDA
-8.87
Div Yield
0.00%
Profitability
Gross Margin
-142.29%
Op Margin
-200.15%
Net Margin
-190.76%
ROE
-84.75%
ROIC
-62.11%
Growth & Income
Revenue
$64.70M · -50.37%
Net Income
$-123,430,000 · -92.85%
EPS
$-1.37 · -53.93%
Op Income
$-129,504,000
FCF YoY
-210.25%
Performance & Tape
52W High
$9.67
52W Low
$1.87
50D MA
$6.66
200D MA
$3.82
Beta
0.54
Avg Volume
1.80M

Get TickerSpark's AI analysis on PSTX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 8, 25Malin Life Sciences Holdings Ltdother11,835,673
Jan 8, 25Amado Rafaelsell55,200
Jan 8, 25Amado Rafaelsell27,350
Jan 8, 25Amado Rafaelother58,950
Jan 8, 25Corning Lukesell27,350
Jan 8, 25Corning Lukesell28,500
Jan 8, 25Corning Lukesell27,350
Jan 8, 25Corning Lukesell45,833
Jan 8, 25Corning Lukeother58,950
Jan 8, 25Schmid John P.sell32,076
Coverage · PSTX

Our PSTX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PSTX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PSTX report →
Internal Compare

Similar companies

Peers in the same neighborhood.